Clinical trials
Squamous Cell Carcinoma of Head and Neck trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 9 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Terminated | 15 |
| Active, not recruiting | 11 |
| Recruiting | 8 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| MacroGenics | 4 |
| Pfizer | 4 |
| AstraZeneca | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| GlaxoSmithKline | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Boehringer Ingelheim | 2 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| Exelixis | 2 |
| Janssen Research & Development, LLC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 60 |
| Head and Neck Neoplasms | 19 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Melanoma | 7 |
| Neoplasm Metastasis | 7 |
| Recurrence | 7 |
| Triple Negative Breast Neoplasms | 7 |
| Carcinoma, Hepatocellular | 5 |
| Carcinoma, Squamous Cell | 5 |
| Uterine Cervical Neoplasms | 5 |
Trials
Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.